0001127602-23-030566.txt : 20231229 0001127602-23-030566.hdr.sgml : 20231229 20231229162419 ACCESSION NUMBER: 0001127602-23-030566 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dahiyat Bassil I CENTRAL INDEX KEY: 0001591312 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36182 FILM NUMBER: 231527993 MAIL ADDRESS: STREET 1: C/O XENCOR, INC. STREET 2: 111 WEST LEMON AVENUE CITY: MONROVIA STATE: CA ZIP: 91016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xencor Inc CENTRAL INDEX KEY: 0001326732 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 201622502 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 465 N. HALSTEAD ST. STREET 2: SUITE 200 CITY: PASADENA STATE: CA ZIP: 91107 BUSINESS PHONE: 626-305-5900 MAIL ADDRESS: STREET 1: 465 N. HALSTEAD ST. STREET 2: SUITE 200 CITY: PASADENA STATE: CA ZIP: 91107 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-12-29 0001326732 Xencor Inc XNCR 0001591312 Dahiyat Bassil I C/O XENCOR, INC. 465 N HALSTEAD STREET, SUITE 200 PASADENA CA 91107 1 1 PRESIDENT & CEO 0 Common Stock 2023-12-29 4 M 0 65001 11.05 A 357929 D Common Stock 2023-12-29 4 S 0 45000 20.926 D 312929 D Stock Option (Right to Buy) 11.05 2023-12-29 4 M 0 65001 0 D 2024-02-20 Common Stock 65001 0 D Underlying option due to expire in February 2024. Includes the following shares acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan: 304 shares acquired in June 2023 and 408 shares acquired in December 2023. Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise. 25% of the shares subject to the option shall vest on the one year anniversary of February 21, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. /s/ Celia E. Eckert, Attorney-in-Fact 2023-12-29